Pregled bibliografske jedinice broj: 483541
Determination of mitotane and its metabolites in biological fluids by SPE-HPLC method
Determination of mitotane and its metabolites in biological fluids by SPE-HPLC method // Internation Scientific and Professional Conference 13th Ružička Days "Today Science - Tomorrow Industry" / Šubarić, Drago (ur.).
Osijek: Prehrambeno tehnološki fakultet Sveučilišta Josipa Jurja Strossmayera u Osijeku, 2010. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 483541 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Determination of mitotane and its metabolites in biological fluids by SPE-HPLC method
Autori
Mornar, Ana ; Sertić, Miranda ; Turk, Nikša ; Koršić, Mirko ; Nigović, Biljana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Internation Scientific and Professional Conference 13th Ružička Days "Today Science - Tomorrow Industry"
/ Šubarić, Drago - Osijek : Prehrambeno tehnološki fakultet Sveučilišta Josipa Jurja Strossmayera u Osijeku, 2010
ISBN
978-953-7005-22-1
Skup
Internation Scientific and Professional Conference 13th Ružička Days "Today Science - Tomorrow Industry"
Mjesto i datum
Vukovar, Hrvatska, 16.09.2010. - 17.09.2010
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
mitotane; metabolites; Solid phase extraction; HPLC; biological fluids
Sažetak
Mitotane is the drug of choice for the treatment of adrenal cortical carcinoma and is used as a chemotherapeutic agent after resection. Its mechanism of action and pharmacokinetics are not fully known. To achieve optimal therapeutic concentration and to prevent dangerous side effects, it is very important to determinate the concentrations levels of mitotane and its metabolites in the body after administration. The aim of this work was to develop and validate a SPE-HPLC method for determination of mitotane and its metabolites in plasma, erythrocytes and urine of a patient with adrenal cortical carcinoma. Blood and urine samples were collected during 8 hours after administration of Lysodrena® (500 mg) pill. SPE conditions: Discovery DSC column, 500 mg, 3 mL (Supelco), preconditioned with 1 mL of methanol and 2 mL of acetonitrile. HPLC conditions: Symmetry C18 column (Waters), 150 × 4.6 mm ; 3.5 μm. Mobile phase: acetonitrile : MiliQ water : formic acid = 90 : 10 : 0.1 ; flow rate 1 mL/min ; DAD detector λmax 230 nm. Method was validated according to ICH guidelines and following parameters were examined: selectivity, linearity, limit of detection and determination, accuracy, precision and robustness. The proposed method was successfully applied for determination of mitotane and its metabolites in plasma, erythrocytes and urine.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Farmacija
POVEZANOST RADA
Projekti:
006-0061117-1240 - Istraživanje novih metoda u analitici ljekovitih i bioaktivnih tvari (Nigović, Biljana, MZOS ) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Biljana Nigović
(autor)
Nikša Turk
(autor)
Mirko Koršić
(autor)
Miranda Sertić
(autor)
Ana Mornar Turk
(autor)